What hormone tests should be ordered in a 28‑year‑old woman presenting with vaginal spotting and pelvic pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hormone Testing for 28-Year-Old with Vaginal Spotting and Pelvic Pain

Order a quantitative serum β-hCG immediately as the first and most critical hormone test to rule out pregnancy complications, particularly ectopic pregnancy, which can be life-threatening. 1, 2

Primary Hormone Testing Algorithm

First-Line (Mandatory)

  • Quantitative serum β-hCG: This is non-negotiable in any reproductive-age woman with vaginal bleeding and pelvic pain. Ectopic pregnancy occurs in up to 13% of symptomatic ED patients and can rupture at any β-hCG level, including very low values 1. The combination of β-hCG with ultrasound findings drives the entire diagnostic algorithm for pregnancy-related complications 1, 2.

  • Serum TSH: Screen for subclinical hypothyroidism, particularly if there is personal or family history of thyroid disease 3. Thyroid dysfunction is a common but often overlooked cause of abnormal uterine bleeding 4.

Second-Line (Based on Clinical Context)

If pregnancy is definitively excluded and clinical features suggest specific endocrine disorders:

  • Serum prolactin: Order if there are signs of hyperprolactinemia or galactorrhea 4, 3

  • Total testosterone and 17-hydroxyprogesterone: Consider if there are signs of hyperandrogenism (hirsutism, acne) suggesting polycystic ovary syndrome (PCOS) 3, 5. Note that total testosterone is the single best hormonal marker for PCOS (abnormal in 70% of cases), superior to LH/FSH ratio 5.

  • Androstenedione: May add diagnostic value in suspected PCOS (abnormal in 53% of cases) 5

Critical Timing Considerations

All hormone sampling must occur between cycle days 1-5 in the early morning hours, ideally fasting 6. This standardization is essential for accurate interpretation, as hormone levels fluctuate throughout the menstrual cycle.

Common Pitfalls to Avoid

  1. Never defer ultrasound based on low β-hCG levels: Ectopic pregnancies present at virtually any β-hCG level, and rupture has been documented at very low levels 1. The discriminatory threshold concept (1,000-2,000 mIU/mL) should not prevent imaging.

  2. Do not order LH/FSH ratio routinely: Despite historical use, this test has poor sensitivity (abnormal in only 41-44% of PCOS cases) and should be abandoned as a primary diagnostic criterion 5.

  3. Avoid broad hormonal panels without clinical indication: Tests like DHEA-S, estradiol, progesterone, and FSH are not first-line for acute vaginal spotting and pelvic pain unless specific clinical features warrant them 4, 3.

Integration with Imaging

The hormone results, particularly β-hCG, must be interpreted alongside transvaginal ultrasound findings 1, 2. Ultrasound is the primary imaging modality and should be performed regardless of β-hCG level when evaluating first-trimester bleeding or pelvic pain in reproductive-age women 2.

If β-hCG is positive, immediate ultrasound evaluation is mandatory to localize the pregnancy and assess viability, as this directly impacts morbidity and mortality outcomes 1, 2.

References

Guideline

acr appropriateness criteria<sup>®</sup> first trimester vaginal bleeding.

Journal of the American College of Radiology, 2018

Research

[Menometrorrhagia: to whom, why, on which criteria to propose a hormonal exploration?].

Journal de gynecologie, obstetrique et biologie de la reproduction, 2008

Research

Evaluation of patients with abnormal uterine bleeding.

American journal of obstetrics and gynecology, 1996

Research

Which hormone tests for the diagnosis of polycystic ovary syndrome?

British journal of obstetrics and gynaecology, 1992

Research

[Screening for gynecologic-endocrinologic problems before menopause].

Therapeutische Umschau. Revue therapeutique, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.